Intravitreal injection of triamcinolone for diffuse diabetic macular edema

JB Jonas, I Kreissig, A Söfker… - Archives of …, 2003 - jamanetwork.com
Objective To evaluate the clinical outcome of an intravitreal injection of triamcinolone
acetonide as treatment of diffuse diabetic macular edema. Participants This prospective,
interventional, clinical case series study included 20 patients (26 eyes) who received an
intravitreal injection of 25 mg of triamcinolone acetonide for treatment of diffuse diabetic
macular edema. Mean±SD follow-up time was 6.64±6.10 months. The study group was
compared with a control group of 16 patients who underwent macular grid laser coagulation …